Thank you to our speakers, sponsors and delegates who joined us in Boston for the summit! If you are interested in the 2024 event, please get in touch at info@hansonwade.com
“A must-go meeting if you work in cell therapy!”
Erika von Euw, Vice President Discovery and Translational Research, Deverra Therapeutics
Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE.
This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.
The 8th CAR-TCR Summit is the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.
The 2023 edition included 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, with 200+ CAR and TCR experts leading over 1,000 cell therapy peers in discussions that will accelerate pipelines, bringing better drugs to patients faster.
Who Attended in 2023:
“Good value, relevant content and useful networking with companies
really active and relevant for the space.”
Helen Tayton-Martin, Chief Business Officer, Adaptimmune Therapeutics



2023 Speakers Included:

Chris Bartiromo
Executive Director, Worldwide Value & Access Strategy, Cell Therapy, Lymphoma & Myeloma
Bristol Myers Squibb
New for 2023!


Frank Neumann
Senior Vice President & Global Head of Clinical Development
Kite, A Gilead Company
New for 2023!


Jennifer Brogdon
Head of Cell & Gene Therapies, Immuno-Oncology & Hematology
Novartis Institutes of BioMedical Research
New for 2023!


Laura McWright
Deputy Director, Seamless Care Models Group
Centers for Medicare & Medicaid Services
New for 2023!


Stephan Grupp
Director, Cancer Immunotherapy & Cell Therapy
Children’s Hospital of Philadelphia
New for 2023!
“Cross-sectional look at the cell therapy industry as a whole. I was impressed from start to finish.”
Damien Fink, Director - Analytical Development, Century Therapeutics